Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
apps
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bio
bluebird bio
boston
boston blog main
boston top stories
clinical trials
disease
duchenne muscular dystrophy
dyne therapeutics
electronic medical records
facioscapulohumeral muscular dystrophy
first round capital
flatiron health
funding
fundings & exits
gene therapy
health
healthcare
joshua brumm
kaleido biosciences
kevin weil
life sciences
lux capital
medical records
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
recent funding
romesh subramanian
san diego blog main
san francisco blog main
What
ago
data
diseases
2
×
rare
2
×
app
attacks
biotechs
called
caused
chat
competitor
considering
diagnosed
disease
drug
dyne
ear
early
expect
expected
experimental
eyes
faber
founder
genetic
having
health
hearing
humans
ipo
ipos
leading
long
lose
medical
medicines
mined
muscle
neurofibromatosis
onno
Language
unset
Current search:
rare
×
biotech
×
diseases
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@techcrunch.com
5 years ago
RDMD attacks rare diseases with data mined from health records
